Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
LabLife Nordic Diagnostics AB
AB
Active
Org 5594589011
Rättarens Väg 9, 182 34
Danderyd
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2023 · 2 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
LabLife Nordic Diagnostics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2024: 1M
1M
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
979
Staff expenses
—
EBITDA
86
Depreciation & amort.
−0
EBIT
86
Net financials
−1
Profit before tax
86
Tax
−18
Net profit
68
Balance sheet
SEK thousands
Item
2024
Total assets
442
Equity
93
Long-term debt
0
Short-term debt
349
Total debt
349
Financial ratios
5-year trend
EBITDA margin
8,8 %
This company
15,8 %
Market median
This company
Market median
44% below market
2024
2024
Equity ratio
21,0 %
This company
38,2 %
Market median
This company
Market median
45% below market
2024
2024
Return on equity
73,1 %
This company
18,4 %
Market median
This company
Market median
297% above market
2024
2024
Net profit margin
6,9 %
This company
8,1 %
Market median
This company
Market median
15% below market
2024
2024
Asset turnover
2,21×
This company
1,12×
Market median
This company
Market median
97% above market
2024
2024
Debt / equity
3,75×
This company
0,62×
Market median
This company
Market median
505% above market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-12-31
View
PDF
More on LabLife Nordic Diagnostics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
